Renetx Bio, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2009-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.renetx.com
Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)AXER-204 in Participants With Chronic Spinal Cord Injury
- First Posted Date
- 2019-06-18
- Last Posted Date
- 2023-08-22
- Lead Sponsor
- ReNetX Bio, Inc.
- Target Recruit Count
- 52
- Registration Number
- NCT03989440
- Locations
- 🇺🇸
Keck Medicine of USC, Los Angeles, California, United States
🇺🇸Shepherd Center, Atlanta, Georgia, United States
🇺🇸Shirley Ryan AbilityLab / Northwestern, Chicago, Illinois, United States
News
No news found